Celal Ulaşoğlu

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Non-alcoholic fatty liver disease – A global public health perspective

Changes of Intestinal Functions in Liver Cirrhosis

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Brain-gut axis in the pathogenesis ofHelicobacter pyloriinfection

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

Mechanisms of NAFLD development and therapeutic strategies

Non-alcoholic fatty liver disease

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1

NAFLD: A multisystem disease

Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis

Inflammation in obesity, diabetes, and related disorders

A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease

Calorie Restriction in Adulthood Reduces Hepatic Disorders Induced by Transient Postnatal Overfeeding in Mice

Insulin-Like Growth Factor (IGF) System in Liver Diseases

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.

Gut Microbiota and Host Reaction in Liver Diseases

TLR4 Gene Polymorphism in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Controls

Effect ofHelicobacter pylorieradication on serum ghrelin and obestatin levels

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease

Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease

A Potential Treatment of Non-Alcoholic Fatty Liver Disease with SIRT1 Activators